4gb9
From Proteopedia
(Difference between revisions)
| Line 1: | Line 1: | ||
| - | [[ | + | ==Potent and Highly Selective Benzimidazole Inhibitors of PI3K-delta== |
| + | <StructureSection load='4gb9' size='340' side='right' caption='[[4gb9]], [[Resolution|resolution]] 2.44Å' scene=''> | ||
| + | == Structural highlights == | ||
| + | <table><tr><td colspan='2'>[[4gb9]] is a 1 chain structure with sequence from [http://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=4GB9 OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=4GB9 FirstGlance]. <br> | ||
| + | </td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=0WR:2-[1-({2-[2-(DIMETHYLAMINO)-1H-BENZIMIDAZOL-1-YL]-9-METHYL-6-(MORPHOLIN-4-YL)-9H-PURIN-8-YL}METHYL)PIPERIDIN-4-YL]PROPAN-2-OL'>0WR</scene></td></tr> | ||
| + | <tr id='gene'><td class="sblockLbl"><b>[[Gene|Gene:]]</b></td><td class="sblockDat">PIK3CG ([http://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?mode=Info&srchmode=5&id=9606 Homo sapiens])</td></tr> | ||
| + | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=4gb9 FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=4gb9 OCA], [http://www.rcsb.org/pdb/explore.do?structureId=4gb9 RCSB], [http://www.ebi.ac.uk/pdbsum/4gb9 PDBsum]</span></td></tr> | ||
| + | </table> | ||
| + | <div style="background-color:#fffaf0;"> | ||
| + | == Publication Abstract from PubMed == | ||
| + | Inhibition of PI3Kdelta is considered to be an attractive mechanism for the treatment of inflammatory diseases and leukocyte malignancies. Using a structure-based design approach, we have identified a series of potent and selective benzimidazole-based inhibitors of PI3Kdelta. These inhibitors do not occupy the selectivity pocket between Trp760 and Met752 that is induced by other families of PI3Kdelta inhibitors. Instead, the selectivity of the compounds for inhibition of PI3Kdelta relative to other PI3K isoforms appears to be due primarily to the strong interactions these inhibitors are able to make with Trp760 in the PI3Kdelta binding pocket. The pharmacokinetic properties and the ability of compound 5 to inhibit the function of B-cells in vivo are described. | ||
| - | + | Potent and Highly Selective Benzimidazole Inhibitors of PI3-Kinase Delta.,Murray JM, Sweeney Z, Chan B, Balazs M, Bradley E, Castanedo G, Chabot C, Chantry D, Flagella M, Goldstein DM, Kondru RK, Lesnick J, Li J, Lucas MC, Nonomiya J, Pang J, Price S, Salphati L, Safina B, Savy P, Seward E, Ultsch M, Sutherlin D J Med Chem. 2012 Aug 9. PMID:22877085<ref>PMID:22877085</ref> | |
| - | + | From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.<br> | |
| + | </div> | ||
| - | + | ==See Also== | |
| - | + | *[[Phosphoinositide 3-Kinases|Phosphoinositide 3-Kinases]] | |
| - | == | + | == References == |
| - | [[ | + | <references/> |
| - | + | __TOC__ | |
| - | == | + | </StructureSection> |
| - | < | + | |
[[Category: Homo sapiens]] | [[Category: Homo sapiens]] | ||
| - | [[Category: Murray, J M | + | [[Category: Murray, J M]] |
[[Category: Kinase]] | [[Category: Kinase]] | ||
[[Category: Kinase p110 gamma-isoform]] | [[Category: Kinase p110 gamma-isoform]] | ||
[[Category: Lipid kinase]] | [[Category: Lipid kinase]] | ||
[[Category: Transferase-transferase inhibitor complex]] | [[Category: Transferase-transferase inhibitor complex]] | ||
Revision as of 09:13, 10 December 2014
Potent and Highly Selective Benzimidazole Inhibitors of PI3K-delta
| |||||||||||
